Ignite Creation Date:
2024-05-06 @ 8:10 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06282874
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-28
First Post:
2024-01-30
Brief Title:
Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases
Sponsor:
Guangdong Association of Clinical Trials
Organization:
Guangdong Association of Clinical Trials
Organization Data
Organization:
Guangdong Association of Clinical Trials
Class:
OTHER
Study ID:
CTONG2303
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Guangdong Association of Clinical Trials
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None